New Insights into the Androgen-Targeted Therapies and Epigenetic Therapies in Prostate Cancer
Prostate cancer is the most common cancer in men in the United States, and it is the second leading cause of cancer-related death in American men. The androgen receptor (AR), a receptor of nuclear family and a transcription factor, is the most important target in this disease. While most efforts in...
Main Authors: | , |
---|---|
Format: | Online |
Language: | English |
Published: |
Hindawi Publishing Corporation
2011
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196248/ |